FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3035222021> ?p ?o ?g. }

• W3035222021 abstract "Glioblastoma, the most common aggressive cancer, has a poor prognosis. Among the current standard treatment strategies, radiation therapy is the most commonly recommended. However, it is often unsuccessful at completely eliminating the cancer from the brain. A combination of radiation with other treatment methods should therefore be considered. It has been reported that radiotherapy in combination with immunotherapy might show a synergistic effect; however, this still needs to be investigated. In the current study, a “branched multipeptide and peptide adjuvants (such as pan DR epitope (PADRE) and polyinosinic-polycytidylic acid—stabilized with polylysine and carboxymethylcellulose—(poly-ICLC))”, namely vaccine and anti-PD1, were used as components of immunotherapy to assist in the anti-tumor effects of radiotherapy against glioblastomas. With regard to experimental design, immunological characterization of GL261 cells was performed and the effects of radiation on this cell line were also evaluated. An intracranial GL261 mouse glioma model was established, and therapeutic effects were observed based on tumor size and survival time. The distribution of effector immune cells in the spleen, based on cytotoxic T lymphocyte (CTL) and natural killer (NK) cell function, was determined. The pro-inflammatory and anti-inflammatory cytokine production from re-stimulated splenocytes and single tumor cells were also evaluated. As GL261 cells demonstrated both immunological characteristics and radiation sensitivity, they were found to be promising candidates for testing this combination treatment. Combinatorial treatment with radiation, vaccine, and anti-PD1 prolonged mouse survival by delaying tumor growth. Although this combination treatment led to an increase in the functional activity of both CTLs and NK cells, as evidenced by the increased percentage of these cells in the spleen, there was a greater shift toward CTL rather than NK cell activity. Moreover, the released cytokines from re-stimulated splenocytes and single tumor cells also showed a shift toward the pro-inflammatory response. This study suggests that immunotherapy comprising a branched multipeptide plus PADRE, poly-ICLC, and anti-PD1 could potentially enhance the anti-tumor effects of radiotherapy in a glioblastoma mouse model." @default.
• W3035222021 created "2020-06-19" @default.
• W3035222021 creator A5021805121 @default.
• W3035222021 creator A5023173605 @default.
• W3035222021 creator A5030214712 @default.
• W3035222021 creator A5039859789 @default.
• W3035222021 creator A5041987846 @default.
• W3035222021 creator A5077683503 @default.
• W3035222021 creator A5078389794 @default.
• W3035222021 creator A5078809425 @default.
• W3035222021 creator A5085034213 @default.
• W3035222021 creator A5090291890 @default.
• W3035222021 date "2020-06-11" @default.
• W3035222021 modified "2023-10-04" @default.
• W3035222021 title "Peptide Vaccine Combined Adjuvants Modulate Anti-tumor Effects of Radiation in Glioblastoma Mouse Model" @default.
• W3035222021 cites W1254161066 @default.
• W3035222021 cites W1517803561 @default.
• W3035222021 cites W1970761320 @default.
• W3035222021 cites W1984265686 @default.
• W3035222021 cites W1985144544 @default.
• W3035222021 cites W2040991839 @default.
• W3035222021 cites W2043871309 @default.
• W3035222021 cites W2053393698 @default.
• W3035222021 cites W2066671159 @default.
• W3035222021 cites W2069220906 @default.
• W3035222021 cites W2078454159 @default.
• W3035222021 cites W2083157454 @default.
• W3035222021 cites W2088665791 @default.
• W3035222021 cites W2110632746 @default.
• W3035222021 cites W2116371946 @default.
• W3035222021 cites W2118278569 @default.
• W3035222021 cites W2127436102 @default.
• W3035222021 cites W2134204495 @default.
• W3035222021 cites W2137405984 @default.
• W3035222021 cites W2144887013 @default.
• W3035222021 cites W2147557533 @default.
• W3035222021 cites W2164001237 @default.
• W3035222021 cites W2170154051 @default.
• W3035222021 cites W2172537925 @default.
• W3035222021 cites W2192976324 @default.
• W3035222021 cites W2257348270 @default.
• W3035222021 cites W2558219863 @default.
• W3035222021 cites W2735587933 @default.
• W3035222021 cites W2755262868 @default.
• W3035222021 cites W2757935580 @default.
• W3035222021 cites W2766295945 @default.
• W3035222021 cites W2791966010 @default.
• W3035222021 cites W2799441834 @default.
• W3035222021 cites W2891491540 @default.
• W3035222021 cites W2940169579 @default.
• W3035222021 cites W2941582519 @default.
• W3035222021 doi "https://doi.org/10.3389/fimmu.2020.01165" @default.
• W3035222021 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7358653" @default.
• W3035222021 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32733437" @default.
• W3035222021 hasPublicationYear "2020" @default.
• W3035222021 type Work @default.
• W3035222021 sameAs 3035222021 @default.
• W3035222021 citedByCount "13" @default.
• W3035222021 countsByYear W30352220212020 @default.
• W3035222021 countsByYear W30352220212021 @default.
• W3035222021 countsByYear W30352220212022 @default.
• W3035222021 countsByYear W30352220212023 @default.
• W3035222021 crossrefType "journal-article" @default.
• W3035222021 hasAuthorship W3035222021A5021805121 @default.
• W3035222021 hasAuthorship W3035222021A5023173605 @default.
• W3035222021 hasAuthorship W3035222021A5030214712 @default.
• W3035222021 hasAuthorship W3035222021A5039859789 @default.
• W3035222021 hasAuthorship W3035222021A5041987846 @default.
• W3035222021 hasAuthorship W3035222021A5077683503 @default.
• W3035222021 hasAuthorship W3035222021A5078389794 @default.
• W3035222021 hasAuthorship W3035222021A5078809425 @default.
• W3035222021 hasAuthorship W3035222021A5085034213 @default.
• W3035222021 hasAuthorship W3035222021A5090291890 @default.
• W3035222021 hasBestOaLocation W30352220211 @default.
• W3035222021 hasConcept C111337013 @default.
• W3035222021 hasConcept C121332964 @default.
• W3035222021 hasConcept C126322002 @default.
• W3035222021 hasConcept C147483822 @default.
• W3035222021 hasConcept C154317977 @default.
• W3035222021 hasConcept C185544564 @default.
• W3035222021 hasConcept C195616568 @default.
• W3035222021 hasConcept C202751555 @default.
• W3035222021 hasConcept C203014093 @default.
• W3035222021 hasConcept C26114605 @default.
• W3035222021 hasConcept C2776789287 @default.
• W3035222021 hasConcept C2777701055 @default.
• W3035222021 hasConcept C2778227246 @default.
• W3035222021 hasConcept C502942594 @default.
• W3035222021 hasConcept C509974204 @default.
• W3035222021 hasConcept C55493867 @default.
• W3035222021 hasConcept C71924100 @default.
• W3035222021 hasConcept C86803240 @default.
• W3035222021 hasConcept C8891405 @default.
• W3035222021 hasConceptScore W3035222021C111337013 @default.
• W3035222021 hasConceptScore W3035222021C121332964 @default.
• W3035222021 hasConceptScore W3035222021C126322002 @default.
• W3035222021 hasConceptScore W3035222021C147483822 @default.
• W3035222021 hasConceptScore W3035222021C154317977 @default.
• W3035222021 hasConceptScore W3035222021C185544564 @default.
• W3035222021 hasConceptScore W3035222021C195616568 @default.

• next